1. Home
  2. FSBC vs OMER Comparison

FSBC vs OMER Comparison

Compare FSBC & OMER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FSBC
  • OMER
  • Stock Information
  • Founded
  • FSBC 2002
  • OMER 1994
  • Country
  • FSBC United States
  • OMER United States
  • Employees
  • FSBC N/A
  • OMER N/A
  • Industry
  • FSBC Banks
  • OMER Biotechnology: Pharmaceutical Preparations
  • Sector
  • FSBC Finance
  • OMER Health Care
  • Exchange
  • FSBC Nasdaq
  • OMER Nasdaq
  • Market Cap
  • FSBC 650.2M
  • OMER 530.2M
  • IPO Year
  • FSBC 2021
  • OMER 2009
  • Fundamental
  • Price
  • FSBC $29.89
  • OMER $9.13
  • Analyst Decision
  • FSBC Buy
  • OMER Buy
  • Analyst Count
  • FSBC 4
  • OMER 4
  • Target Price
  • FSBC $36.13
  • OMER $22.50
  • AVG Volume (30 Days)
  • FSBC 44.9K
  • OMER 509.4K
  • Earning Date
  • FSBC 01-27-2025
  • OMER 03-31-2025
  • Dividend Yield
  • FSBC 2.69%
  • OMER N/A
  • EPS Growth
  • FSBC N/A
  • OMER N/A
  • EPS
  • FSBC 2.26
  • OMER N/A
  • Revenue
  • FSBC $119,214,000.00
  • OMER N/A
  • Revenue This Year
  • FSBC N/A
  • OMER N/A
  • Revenue Next Year
  • FSBC $15.51
  • OMER N/A
  • P/E Ratio
  • FSBC $13.38
  • OMER N/A
  • Revenue Growth
  • FSBC 4.22
  • OMER N/A
  • 52 Week Low
  • FSBC $21.10
  • OMER $2.61
  • 52 Week High
  • FSBC $35.13
  • OMER $13.60
  • Technical
  • Relative Strength Index (RSI)
  • FSBC 41.97
  • OMER 50.45
  • Support Level
  • FSBC $28.95
  • OMER $8.28
  • Resistance Level
  • FSBC $31.50
  • OMER $9.08
  • Average True Range (ATR)
  • FSBC 0.96
  • OMER 0.58
  • MACD
  • FSBC 0.08
  • OMER -0.05
  • Stochastic Oscillator
  • FSBC 26.14
  • OMER 62.58

About FSBC Five Star Bancorp

Five Star Bancorp is a California state-chartered non-member bank. The Company provides a broad range of banking products and services to small and medium-sized businesses, professionals, and individuals. It offers loan products like commercial real estate loans, commercial loans, commercial land and construction loans, and farmland loans and offers deposit products like checking accounts, savings accounts, money market accounts, and term certificate accounts.

About OMER Omeros Corporation

Omeros Corp is a United States-based clinical-stage biopharmaceutical company engaged in discovering, developing, and commercializing small-molecule and protein therapeutics for large-market as well as orphan indications targeting immunologic disorders including complement-mediated diseases, cancers, and addictive and compulsive disorders. The lead drug candidate in the pipeline of complement-targeted therapeutics is narsoplimab (OMS721), a proprietary, patented human monoclonal antibody targeting mannan-binding lectin-associated serine protease 2, the key activator of the lectin pathway of complement. Clinical development of narsoplimab is currently focused on hematopoietic stem cell transplant-associated thrombotic microangiopathy and immunoglobulin nephropathy.

Share on Social Networks: